These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19104029)

  • 1. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
    Parize P; Chandesris MO; Lanternier F; Poirée S; Viard JP; Bienvenu B; Mimoun M; Méchai F; Mamzer MF; Herman P; Bougnoux ME; Lecuit M; Lortholary O
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1048-53. PubMed ID: 19104029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
    Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C
    Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
    Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with voriconazole in invasive aspergillosis].
    Thiel E; Schwartz S
    Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
    Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
    Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Voriconazole - applications and perspectives].
    Ruhnke M
    Mycoses; 2002; 45 Suppl 3():42-7. PubMed ID: 12690971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
    J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
    Chirch L; Roche P; Fuhrer J
    Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review.
    Pichon M; Joly V; Argy N; Houze S; Bretagne S; Alanio A; Wassef M; Verillaud B; Yazdanpanah Y
    Infection; 2020 Apr; 48(2):193-203. PubMed ID: 32036556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
    Shouldice E; Fernandez C; McCully B; Schmidt M; Fraser R; Cook C
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):732-4. PubMed ID: 12972810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
    Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH
    Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
    Klein KC; Blackwood RA
    Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspergillus spp. invasive external otitis: favourable outcome with a medical approach.
    Marchionni E; Parize P; Lefevre A; Vironneau P; Bougnoux ME; Poiree S; Coignard-Biehler H; DeWolf SE; Amazzough K; Barchiesi F; Jullien V; Alanio A; Garcia-Hermoso D; Wassef M; Kania R; Lortholary O; Lanternier F
    Clin Microbiol Infect; 2016 May; 22(5):434-7. PubMed ID: 26802213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral voriconazole for invasive fungal skull base infection.
    Parsonage MJ; Stafford ND; Lillie P; Moss PJ; Barlow G; Thaker H
    J Laryngol Otol; 2010 Sep; 124(9):1010-3. PubMed ID: 20028605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.
    Ayçiçek A; Cetinkaya Z; Kiyici H; Kenar F; Aşik G; Kiraz N
    Eur Arch Otorhinolaryngol; 2009 Nov; 266(11):1703-9. PubMed ID: 19340446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.